-transparent.png){kind=logo}
Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group. 1979
S I Lamberg, and
S B Green, and
D P Byar, and
J B Block, and
W E Clendenning, and
E H Epstein, and
Z Y Fuks, and
L E Golitz, and
A L Lorincz, and
B Michel, and
H H Roenigk, and
E J Van Scott, and
E C Vonderheid, and
R J Thomas
The frequency and prognostic importance of various characteristics of patients registered by the Mycosis Fungoides Cooperative Group between November 1974 and December 1977 are reported. Variables which were considered include demographic and historical factors, symptoms, extent of disease, and other physical findings. A staging system which is based on the extent of skin involvement and the number of nodal sites clinically involved is described. Finally, a description of therapeutic results to date for patients randomized into Mycosis Fungoides Cooperative Group protocols is presented.
Related Publications
S I Lamberg, and
S B Green, and
D P Byar, and
J B Block, and
W E Clendenning, and
E H Epstein, and
Z Y Fuks, and
L E Golitz, and
A L Lorincz, and
B Michel, and
H H Roenigk, and
E J Van Scott, and
E C Vonderheid, and
R J Thomas
April 1975,
Archives of dermatology,
S I Lamberg, and
S B Green, and
D P Byar, and
J B Block, and
W E Clendenning, and
E H Epstein, and
Z Y Fuks, and
L E Golitz, and
A L Lorincz, and
B Michel, and
H H Roenigk, and
E J Van Scott, and
E C Vonderheid, and
R J Thomas
January 1979,
Acta dermato-venereologica,
S I Lamberg, and
S B Green, and
D P Byar, and
J B Block, and
W E Clendenning, and
E H Epstein, and
Z Y Fuks, and
L E Golitz, and
A L Lorincz, and
B Michel, and
H H Roenigk, and
E J Van Scott, and
E C Vonderheid, and
R J Thomas
January 1985,
Acta dermato-venereologica,
S I Lamberg, and
S B Green, and
D P Byar, and
J B Block, and
W E Clendenning, and
E H Epstein, and
Z Y Fuks, and
L E Golitz, and
A L Lorincz, and
B Michel, and
H H Roenigk, and
E J Van Scott, and
E C Vonderheid, and
R J Thomas
February 1980,
Cutis,
S I Lamberg, and
S B Green, and
D P Byar, and
J B Block, and
W E Clendenning, and
E H Epstein, and
Z Y Fuks, and
L E Golitz, and
A L Lorincz, and
B Michel, and
H H Roenigk, and
E J Van Scott, and
E C Vonderheid, and
R J Thomas
December 1978,
Arizona medicine,
S I Lamberg, and
S B Green, and
D P Byar, and
J B Block, and
W E Clendenning, and
E H Epstein, and
Z Y Fuks, and
L E Golitz, and
A L Lorincz, and
B Michel, and
H H Roenigk, and
E J Van Scott, and
E C Vonderheid, and
R J Thomas
April 1980,
The British journal of dermatology,
S I Lamberg, and
S B Green, and
D P Byar, and
J B Block, and
W E Clendenning, and
E H Epstein, and
Z Y Fuks, and
L E Golitz, and
A L Lorincz, and
B Michel, and
H H Roenigk, and
E J Van Scott, and
E C Vonderheid, and
R J Thomas
January 1979,
Acta dermato-venereologica,
S I Lamberg, and
S B Green, and
D P Byar, and
J B Block, and
W E Clendenning, and
E H Epstein, and
Z Y Fuks, and
L E Golitz, and
A L Lorincz, and
B Michel, and
H H Roenigk, and
E J Van Scott, and
E C Vonderheid, and
R J Thomas
January 1984,
Acta dermato-venereologica,
S I Lamberg, and
S B Green, and
D P Byar, and
J B Block, and
W E Clendenning, and
E H Epstein, and
Z Y Fuks, and
L E Golitz, and
A L Lorincz, and
B Michel, and
H H Roenigk, and
E J Van Scott, and
E C Vonderheid, and
R J Thomas
January 1977,
Bulletin du cancer,
S I Lamberg, and
S B Green, and
D P Byar, and
J B Block, and
W E Clendenning, and
E H Epstein, and
Z Y Fuks, and
L E Golitz, and
A L Lorincz, and
B Michel, and
H H Roenigk, and
E J Van Scott, and
E C Vonderheid, and
R J Thomas
January 1981,
Acta dermato-venereologica,
